Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease

Background: Fabry cardiomyopathy is characterized by left ventricular hypertrophy, myocardial fibrosis, arrhythmia, and premature death. Treatment with migalastat, an oral pharmacological chaperone, was associated with a stabilization of cardiac biomarkers and a reduction in left ventricular mass in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatterer, Constantin, Beitzke, Dietrich, Graf, Senta, Lenz, Max, Sunder-Plassmann, Gere, Mann, Christopher, Ponleitner, Markus, Manka, Robert, Fritschi, Daniel, Krayenbuehl, Pierre-Alexandre, Kamm, Philipp, Dormond, Olivier, Barbey, Frédéric, Monney, Pierre, Nowak, Albina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222787/
https://www.ncbi.nlm.nih.gov/pubmed/37240859
http://dx.doi.org/10.3390/life13051213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222787/
https://www.ncbi.nlm.nih.gov/pubmed/37240859
http://dx.doi.org/10.3390/life13051213

Ejemplares similares